South Africa Plays Role in AIDS Vaccine Discovery Efforts
IAVI awards South Africa’s Elevation Biotech with an innovation grant to help develop novel vaccine immunogens that elicit broadly neutralizing antibodies against HIV.
New AIDS Vaccine Research Center Established
IAVI and The Scripps Research Institute have launched the world’s first research center dedicated exclusively to solving the most pressing challenge facing AIDS vaccine researchers today—how to elicit broadly neutralizing antibodies against HIV.
Strengthening the response to HIV and AIDS: Helping make the MDGs a reality
A new IAVI policy brief, endorsed by 43 partner organizations, examines the critical role that the response to HIV/AIDS plays in advancing the Millennium Development Goals.
Responding to AIDS: A Call for Japanese Support for Vaccine Development
An opinion piece published in Japan’s Asahi newspaper, authored by Sir Richard Feachem, calls upon Japan to contribute its world-class technology and financial resources to the research and development of preventive vaccines for infectious diseases—particularly an AIDS vaccine.
IAVI releases new policy briefs on approval and procurement of vaccines
These new publications help explain the important processes of ensuring that safe, effective, affordable vaccines are made available to developing countries.
IAVI and Indian Government Announce Results of Phase I AIDS Vaccine Trial
A phase I clinical trial of an MVA-based AIDS vaccine candidate was successfully completed in India, the results of which showed the vaccine candidate had acceptable levels of safety and was well tolerated.
|
New York:
